share_log

Cantor Fitzgerald Maintains Overweight on Prothena Corp, Lowers Price Target to $87

Benzinga ·  Jan 9 09:08

Cantor Fitzgerald analyst Charles Duncan maintains Prothena Corp (NASDAQ:PRTA) with a Overweight and lowers the price target from $129 to $87.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment